New Cleveland Clinic-led research shows commonly used COVID-19 anti-viral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduce risk of hospitalization and death in high-risk patients with mild disease, even with ...
Sep 28, 2023
0
19
A first-in-human trial of deep brain stimulation (DBS) for post-stroke rehabilitation patients by Cleveland Clinic researchers has shown that using DBS to target the dentate nucleus—which regulates fine-control of voluntary ...
Aug 14, 2023
0
64
New research shows how doctors can improve the timing of surgery for some heart attack patients by analyzing the levels of a particular protein.
Oct 3, 2022
0
75
Some people and animals grow arteries that allow blood to bypass blockages in the heart. But to engineer these bypasses to serve as lifelines, scientists first need to understand how they work. Researchers have now modeled ...
Aug 29, 2022
0
73
Cardiac surgery patients may experience different levels of disruption to their body producing life-saving hormones during their operations, a new study reveals.
Apr 29, 2022
0
21
A new study that monitors patients who received "on-pump" or "off-pump" coronary artery bypass grafting (CABG) over a 10-year period reveals that outcomes between the two forms of heart bypass surgery are not much different. ...
Feb 18, 2022
0
41
Men with stable coronary artery disease who are on Viagra due to impotence seem to live longer and have a lower risk of experiencing a new heart attack, a study from Karolinska Institutet in Sweden published in the Journal ...
Mar 22, 2021
0
446
Researchers may be closer to improving the lives of people with coronary artery disease and children born with pediatric congenital cardiovascular defects through the development of a new vascular graft created by Johns Hopkins ...
Jul 1, 2019
0
2
Research from three Yale laboratories—in the fields of immunobiology, chemistry, and cardiology—could lead to new drugs to reduce complications during cardiac surgery or heart attacks. If they pan out in human trials, ...
Jul 24, 2013
0
0
The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing ...
Aug 26, 2012
0
0
